🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
The study aims at piloting the concept of customization of chemotherapy bas...
Status
Terminated
Location
King Abdul Aziz Medical City for National Guard Health Affairs
Start Date
2010-05
Trial ID
NCT01356368
Treatments Being Tested
This study was conducted to compare the activities of erlotinib to that of ...
Status
Terminated
Location
Lovelace Medical Group
Start Date
2006-07
Trial ID
NCT00391586
Treatments Being Tested
This phase III trial compares standard therapy given after surgery (adjuvan...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-12-11
Trial ID
NCT06632327
To determine the best dose of this investigational agent AG-013736 in combi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00454649
Treatments Being Tested
This is an open-label study. This means that people in this study and clini...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2022-06-08
Trial ID
NCT05382559
In this trial, subjects with chemo-naive advanced non-small cell lung cance...
Status
Terminated
Location
Duke University Medical Center
Start Date
2007-05
Trial ID
NCT00509366
Treatments Being Tested